| Spatially resolved clonal copy number alterations in benign and malignant tissue A Erickson, M He, E Berglund, M Marklund, R Mirzazadeh, N Schultz, ... Nature 608 (7922), 360-367, 2022 | 192 | 2022 |
| Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse S Taavitsainen, N Engedal, S Cao, F Handle, A Erickson, S Prekovic, ... Nature communications 12 (1), 5307, 2021 | 93 | 2021 |
| PTEN loss but not ERG expression in diagnostic biopsies is associated with increased risk of progression and adverse surgical findings in men with prostate cancer on active … U Lokman, AM Erickson, H Vasarainen, AS Rannikko, T Mirtti European urology focus 4 (6), 867-873, 2018 | 61 | 2018 |
| Loss of PTEN expression in ERG-negative prostate cancer predicts secondary therapies and leads to shorter disease-specific survival time after radical prostatectomy K Lahdensuo, A Erickson, I Saarinen, H Seikkula, J Lundin, M Lundin, ... Modern Pathology 29 (12), 1565-1574, 2016 | 58 | 2016 |
| Fibroblast as a critical stromal cell type determining prognosis in prostate cancer S Blom, A Erickson, A Östman, A Rannikko, T Mirtti, O Kallioniemi, ... The Prostate 79 (13), 1505-1513, 2019 | 35 | 2019 |
| New prostate cancer grade grouping system predicts survival after radical prostatectomy A Erickson, K Sandeman, K Lahdensuo, S Nordling, M Kallajoki, ... Human pathology 75, 159-166, 2018 | 34 | 2018 |
| Repeat multiparametric MRI in prostate cancer patients on active surveillance JT Eineluoto, P Järvinen, A Kenttämies, TP Kilpeläinen, H Vasarainen, ... PloS one 12 (12), e0189272, 2017 | 34 | 2017 |
| A systematic review of prostate cancer heterogeneity: Understanding the clonal ancestry of multifocal disease A Erickson, A Hayes, T Rajakumar, C Verrill, RJ Bryant, FC Hamdy, ... European urology oncology 4 (3), 358-369, 2021 | 31 | 2021 |
| Ductal adenocarcinoma of the prostate: a systematic review and meta‐analysis of incidence, presentation, prognosis, and management N Ranasinha, A Omer, Y Philippou, E Harriss, L Davies, K Chow, ... BJUI compass 2 (1), 13-23, 2021 | 29 | 2021 |
| Morphological Features Extracted by AI Associated with Spatial Transcriptomics in Prostate Cancer E Chelebian, C Avenel, K Kartasalo, M Marklund, A Tanoglidi, T Mirtti, ... Cancers 13 (19), 4837, 2021 | 28 | 2021 |
| Increased HSF1 expression predicts shorter disease-specific survival of prostate cancer patients following radical prostatectomy JK Björk, I Ahonen, T Mirtti, A Erickson, A Rannikko, A Bützow, S Nordling, ... Oncotarget 9 (58), 31200, 2018 | 28 | 2018 |
| Enzalutamide-induced feed-forward signaling loop promotes therapy-resistant prostate cancer growth providing an exploitable molecular target for Jak2 inhibitors V Udhane, C Maranto, DT Hoang, L Gu, A Erickson, S Devi, PG Talati, ... Molecular cancer therapeutics 19 (1), 231-246, 2020 | 25 | 2020 |
| Multiplex immunohistochemical phenotyping of T cells in primary prostate cancer B Ozbek, O Ertunc, A Erickson, ID Vidal, C Gomes‐Alexandre, G Guner, ... The Prostate 82 (6), 706-722, 2022 | 19 | 2022 |
| Positive STAT5 protein and locus amplification status predicts recurrence after radical prostatectomy to assist clinical precision management of prostate cancer BR Haddad, A Erickson, V Udhane, PS LaViolette, JD Rone, MA Kallajoki, ... Cancer Epidemiology, Biomarkers & Prevention 28 (10), 1642-1651, 2019 | 16 | 2019 |
| Increase of prostate biopsy-related bacteremic complications in southern Finland, 2005–2013: a population-based analysis K Lahdensuo, A Rannikko, VJ Anttila, A Erickson, A Pätäri-Sampo, ... Prostate cancer and prostatic diseases 19 (4), 417-422, 2016 | 15 | 2016 |
| Prostate MRI added to CAPRA, MSKCC and Partin cancer nomograms significantly enhances the prediction of adverse findings and biochemical recurrence after radical prostatectomy K Sandeman, JT Eineluoto, J Pohjonen, A Erickson, TP Kilpeläinen, ... Plos one 15 (7), e0235779, 2020 | 14 | 2020 |
| Grading Evolution and Contemporary Prognostic Biomarkers of Clinically Significant Prostate Cancer K Sopyllo, AM Erickson, T Mirtti Cancers 13 (4), 628, 2021 | 13 | 2021 |
| Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones M Marklund, N Schultz, S Friedrich, E Berglund, F Tarish, A Tanoglidi, ... Nature Communications 13 (1), 5475, 2022 | 11 | 2022 |
| Infectious complications after transrectal MRI-targeted and systematic prostate biopsy I Kalalahti, K Huotari, A Erickson, A Petas, H Vasarainen, A Rannikko World Journal of Urology 40 (9), 2261-2265, 2022 | 8 | 2022 |
| Transcript analysis of commercial prostate cancer risk stratification panels in hard‐to‐predict grade group 2–4 prostate cancers TPK Lehto, C Stürenberg, A Malén, AM Erickson, H Koistinen, IG Mills, ... The Prostate 81 (7), 368-376, 2021 | 8 | 2021 |